Trade Standard BioTools Inc - LAB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0200 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.855 |
| Open | 1.805 |
| 1-Year Change | -8.55% |
| Day's Range | 1.805 - 1.855 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 1.8150 | 0.0100 | 0.55% | 1.8050 | 1.8550 | 1.7950 |
| Dec 23, 2024 | 1.8550 | -0.0700 | -3.64% | 1.9250 | 1.9750 | 1.8150 |
| Dec 20, 2024 | 1.9850 | 0.0600 | 3.12% | 1.9250 | 2.0350 | 1.8850 |
| Dec 19, 2024 | 1.9750 | 0.0100 | 0.51% | 1.9650 | 1.9950 | 1.9250 |
| Dec 18, 2024 | 1.9750 | -0.2200 | -10.02% | 2.1950 | 2.2350 | 1.9750 |
| Dec 17, 2024 | 2.1950 | 0.0700 | 3.29% | 2.1250 | 2.2350 | 2.0750 |
| Dec 16, 2024 | 2.1450 | 0.2800 | 15.01% | 1.8650 | 2.1550 | 1.8650 |
| Dec 13, 2024 | 1.8950 | 0.0100 | 0.53% | 1.8850 | 1.9050 | 1.8150 |
| Dec 12, 2024 | 1.9150 | 0.0000 | 0.00% | 1.9150 | 1.9750 | 1.9150 |
| Dec 11, 2024 | 1.9350 | -0.0800 | -3.97% | 2.0150 | 2.0150 | 1.8650 |
| Dec 10, 2024 | 2.0150 | 0.1400 | 7.47% | 1.8750 | 2.0450 | 1.8550 |
| Dec 9, 2024 | 1.9250 | 0.1400 | 7.84% | 1.7850 | 1.9750 | 1.7450 |
| Dec 6, 2024 | 1.8050 | 0.0600 | 3.44% | 1.7450 | 1.8250 | 1.7150 |
| Dec 5, 2024 | 1.7550 | -0.0500 | -2.77% | 1.8050 | 1.8350 | 1.7450 |
| Dec 4, 2024 | 1.8350 | 0.0500 | 2.80% | 1.7850 | 1.8650 | 1.7550 |
| Dec 3, 2024 | 1.8250 | -0.0900 | -4.70% | 1.9150 | 1.9350 | 1.8050 |
| Dec 2, 2024 | 1.9350 | 0.1600 | 9.01% | 1.7750 | 1.9450 | 1.7750 |
| Nov 29, 2024 | 1.8350 | 0.0300 | 1.66% | 1.8050 | 1.8450 | 1.7850 |
| Nov 27, 2024 | 1.8150 | 0.0900 | 5.22% | 1.7250 | 1.8550 | 1.7050 |
| Nov 26, 2024 | 1.7050 | 0.1100 | 6.90% | 1.5950 | 1.7050 | 1.5750 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Standard BioTools Inc Company profile
About Fluidigm Corporation
Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Fluidigm Corporation revenues decreased 5% to $130.6M. Net loss increased 12% to $59.2M. Revenues reflect Development revenue segment decrease of 71% to $2.6M, Instruments segment decrease of 7% to $42.5M, United States segment decrease of 16% to $60.2M, Asia-Pacific segment decrease of 7% to $24M. Higher net loss reflects Research and development increase of 4% to $37.9M (expense), Selling.
Equity composition
Common Stock $0.001 Par, 2/11, 19,938,754 auth, 19,938,754 issd. Insiders own approx. 11.14%.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
2 Tower Place
Suite 2000
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com